OncoSec Medical

About:

OncoSec is a biotechnology company focusing on designing and developing gene therapies, therapeutics, and medical approaches.

Website: http://oncosec.com

Twitter/X: Oncosec

Top Investors: National Institutes of Health, Alpha Holdings

Description:

OncoSec Medical is an advanced-stage biomedical company that focuses on the development of novel therapeutic oncology products. The company's core technology is an untapped delivery system, that applies short electric impulses to a tumor, causing transient pores to open in the cellular membrane, allowing therapeutic agents to more readily enter cancer cells. This process is known as OMS electroporation. Using OMS electroporation in tandem with chemotherapeutic or biologic agents can selectively and effectively treat cancerous tumors and cells embedded among predominantly healthy tissue.

Total Funding Amount:

$143M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

San Diego, California, United States

Founded Date:

2008-01-01

Contact Email:

investors(AT)oncosec.com

Founders:

Punit Dhillon

Number of Employees:

51-100

Last Funding Date:

2023-05-16

IPO Status:

Public

Industries:

© 2025 bioDAO.ai